Format

Send to

Choose Destination
Bone Marrow Transplant. 2018 Jun;53(6):795-799. doi: 10.1038/s41409-018-0124-6. Epub 2018 Mar 14.

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia.

Author information

1
Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN, USA. katie.s.gatwood@vanderbilt.edu.
2
Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN, USA.
3
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
4
Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
PMID:
29540851
DOI:
10.1038/s41409-018-0124-6

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center